27
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Cardiac Arrest Following an Iatrogenic 3, 4-Diaminopyridine Intoxication in a Patient with Lambert-Eaton Myasthenic Syndrome

, , &
Pages 249-251 | Published online: 25 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Shin J. Oh. (2019) Amifampridine for the treatment of Lambert-Eaton myasthenic syndrome. Expert Review of Clinical Immunology 15:10, pages 991-1007.
Read now
Paul Maddison, Michael J Keogh & Saam Sedehizadeh. (2014) Profile of aminopyridines for Lambert–Eaton myasthenic syndrome. Orphan Drugs: Research and Reviews 4, pages 11-18.
Read now
Sabine Lindquist & Martin Stangel. (2011) Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine. Neuropsychiatric Disease and Treatment 7, pages 341-349.
Read now
Paul W Wirtz, Maarten J Titulaer, Joop MA van Gerven & Jan J Verschuuren. (2010) 3,4-diaminopyridine for the treatment of Lambert–Eaton myasthenic syndrome. Expert Review of Clinical Immunology 6:6, pages 867-874.
Read now
A. Quartel, S. Turbeville & D. Lounsbury. (2010) Current therapy for Lambert–Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Current Medical Research and Opinion 26:6, pages 1363-1375.
Read now
Jan JGM Verschuuren, Paul W Wirtz, Maarten J Titulaer, Luuk NA Willems & Joop van Gerven. (2006) Available treatment options for the management of Lambert-Eaton myasthenic syndrome. Expert Opinion on Pharmacotherapy 7:10, pages 1323-1336.
Read now
Yesim Tuncok, Sebnem Apaydin, Ayse Gelal, Mehmet Ates & Hulya Guven. (1998) The Effects of 4-Aminopyridine and Bay K 8644 on Verapamil-Induced Cardiovascular Toxicity in Anesthetized Rats. Journal of Toxicology: Clinical Toxicology 36:4, pages 301-307.
Read now

Articles from other publishers (13)

. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 913 .
Renato Mantegazza, Andreas Meisel, Joern P. Sieb, Gwendal Le Masson, Claude Desnuelle & Mirko Essing. (2015) The European LEMS Registry: Baseline Demographics and Treatment Approaches. Neurology and Therapy 4:2, pages 105-124.
Crossref
Paul Maddison. (2012) Treatment in Lambert-Eaton myasthenic syndrome. Annals of the New York Academy of Sciences 1275:1, pages 78-84.
Crossref
Andrew M. King, Nathan B. Menke, Kenneth D. Katz & Anthony F. Pizon. (2012) 4-Aminopyridine Toxicity: a Case Report and Review of the Literature. Journal of Medical Toxicology 8:3, pages 314-321.
Crossref
Saam Sedehizadeh, Michael Keogh & Paul Maddison. (2012) The Use of Aminopyridines in Neurological Disorders. Clinical Neuropharmacology 35:4, pages 191-200.
Crossref
Maarten J Titulaer, Bethan Lang & Jan JGM Verschuuren. (2011) Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. The Lancet Neurology 10:12, pages 1098-1107.
Crossref
Donald B. Sanders & Vern C. Juel. 2008. Neuromuscular Junction Disorders. Neuromuscular Junction Disorders 273 283 .
A. Yachachi Monfort, F. Cortés Pastor, A. de la Rubia Nieto & M.J. Sánchez Garre. (2007) Tratamiento del síndrome de Lambert-Eaton con 3,4-diaminopiridina y piridostigmina. Farmacia Hospitalaria 31:4, pages 254-255.
Crossref
DONALD B. SANDERS. (2003) Lambert-Eaton Myasthenic Syndrome. Annals of the New York Academy of Sciences 998:1, pages 500-508.
Crossref
Larissa Velez, Farshad Shirazi, Collin Goto, Greene Shepherd & Brett A. Roth. (2003) Opisthotonic Posturing With Neuromuscular Irritability Attributable to 4-Aminopyridine Ingestion by a Healthy Pediatric Patient. Pediatrics 111:1, pages e82-e84.
Crossref
C. Michel Harper & Vanda A. Lennon. 2003. Myasthenia Gravis and Related Disorders. Myasthenia Gravis and Related Disorders 269 291 .
John Newsom-Davis. (2001) Lambert-eaton myasthenic syndrome. Current Treatment Options in Neurology 3:2, pages 127-131.
Crossref
Dae S. Kim, Gwendolyn C. Claussen & Shin J. Oh. (1998) Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome. Muscle & Nerve 21:8, pages 1107-1108.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.